Our Products
Designed for deep and tunneling wounds
Designed for management of advanced wounds
Designed for delivery to tunneling wounds
Perfusion Decellularization Technology
With Reprise’s proprietary perfusion decellularization, the main vasculature of the liver is cannulated and perfused with a mild solution through the native vessels. The result is a preserved collagen scaffold with vasculature that retains strength and a micro-environment for cellular integration.
Events
SAM 2024 – January 24-28
See us in January at the Science & Management Symposium (SAM) Meeting, organized by the Florida Podiatric Medical Association, in Orlando, Florida.
Conference Website >
News
Reprise Biomedical’s Miro3D® Wound Matrix Granted Level II HCPCS Code by CMS
Customer Resources
Find reimbursement and ordering information here
Our Company
Reprise Biomedical is led by an experienced medical device management team with a record of success in commercializing biologic medical devices.
SM-00140 Rev. F 12/23